The expansion, supported by a significant UK government grant, includes a new lipid system synthesis facility and enhanced R&D capabilities
Ultra-high purity surfactant for biologics and parenteral drug formulations
Zydus Pinkathon will be led by women to raise awareness on breast cancer and women's health
Sessions will cover process mapping, cost optimisation, data-driven decision-making, cybersecurity, and sustainable manufacturing practices
Alkem's Pertuza is an affordable, indigenously-developed and manufactured biosimilar of pertuzumab
The positive opinion is based on results from KOMET, the largest and only placebo-controlled, double-blind global Phase III trial in this patient population
The facility has been classified as Voluntary Action Indicated
Subscribe To Our Newsletter & Stay Updated
